EP. 1: Second Opinion: Cost of Care for Non-Small Cell Lung Cancer
May 27th 2021
Dr. Rachel Sanborn and Yousuf Gaffar discuss the cost of care in advanced NSCLC, frontline treatment options for patients without driver mutations, and optimal adverse effect management strategies for approved immunotherapy regimens.
EP. 2: Second Opinion: Working Mothers in Pharmacy
Suzanne Soliman and Sally Arif discuss how the COVID-19 pandemic has impacted women in pharmacy, especially mothers.
EP. 3: Second Opinion: Real World Eye-Care
May 21st 2021
Dr. Ehsan Sadri and Dr. Farrell “Toby” Tyson join Second Opinion to discuss real world eye-care topics.
EP. 4: Second Opinion: EPISTOP's Impact on Clinical Care
Dr. Eric Segal and Dr. Jurriaan Peters discuss the recently published EPISTOP trial in tuberous sclerosis complex, including its strengths and weaknesses, its implications for clinical practice, and how they approach patient management for this rare epilepsy.
EP. 5: Second Opinion: Urology Guideline Updates
May 17th 2021
Mark Painter and Dr. Jonathan Rubenstein join Second Opinion to discuss the Centers for Medicare & Medicaid Services’ recently issued technical corrections to the new evaluation and management guidelines.
EP. 6: Second Opinion: The Scientific Side of Social Media
Dr. Brian R. Stork and Dr. Stacy Loeb join Second Opinion to discuss the positives of physicians use of social media.
EP. 7: Second Opinion: Genetic Variation and Fish Oil Supplementation
Dr. Kristina Harris Jackson and Dr. William S. Harris join Second Opinion to discuss diet science.
EP. 8: Second Opinion: ASH 2020 Takeaways for Myelofibrosis
Dr. Ruben Mesa and Dr. Aaron Gerds discuss the current landscape of myelofibrosis and key takeaways from the 2020 ASH Annual Meeting and Exposition in this rare cancer.
EP. 9: Second Opinion: Liver Effects of CBD
Dr. Jeff Lombardo and Dr. Keith Aqua, both co-investigators of the Validcare study on observing potential liver effects in adults who are using a form of hemp-derived cannabidiol (CBD) for a minimum of 60 days, join Second Opinion to highlight key insights, including what prompted the study, preliminary results, their meeting with the FDA, and what’s next.
EP. 10: Second Opinion: Scenarios from the Veterinarian's Office
Dr. Marc Rosenberg and Bash Halow join Second Opinion to dive into a few potentially puzzling scenarios right from the floor of a veterinarian's office.
EP. 11: Second Opinion: Managing Migraine: Pregnancy, Pain, Stigma
Dr. Jessica Ailani and Dr. Deena Kuruvilla join Second Opinion to discuss managing migraines.
EP. 12: Second Opinion: Lessons on Leukemia
Dr. Naval Daver and Dr. Amir Fathi, leading experts in the management of patients with acute myeloid leukemia (AML), join Second Opinion.
EP. 13: Second Opinion: Blood Cultures and Patient Outcomes
Majdi Al-Hasan and P. Brandon Bookstaver join Second Opinion to discuss the role of follow up blood cultures in the management of gram-negative bloodstream infection based on recent literature
EP. 14: Second Opinion: Sequencing Gastrointestinal Stromal Tumors
Dr. Fadi Braiteh and Dr. Brian Van Tine join Second Opinion to discuss sequencing gastrointestinal stromal tumors.
EP. 15: Second Opinion: Addressing COVID-19 Vaccine Hesitancy
Sally Arif and Suzanne Soliman join Second Opinion to discuss COVID-19 vaccine hesitancy and promoting vaccine confidence.
